Is my portfolio
One Report to Answer all your Questions!
Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
902.15
10.60 (1.19%) Cadila Healthcare informs about loss of share certificate
Date: 05-02-2022Cadila Healthcare has informed that it attached intimation on loss of share certificate as per Regulation 39(3) of SEBI (LODR), 2015.
The above information is a part of company’s filings submitted to BSE.